The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Large retroperitoneal lymph nodes (RPLN) as a novel risk factor for venous thromboembolism (VTE) in germ cell tumor (GCT) patients (pts) receiving first-line chemotherapy (chemo).
Ben Tran
No relevant relationships to disclose
Michel S Beausoleil
No relevant relationships to disclose
Eitan Amir
No relevant relationships to disclose
Michael A Jewett
No relevant relationships to disclose
Jeremy F. G. Sturgeon
No relevant relationships to disclose
Lynn Anson-Cartwright
No relevant relationships to disclose
Peter W. M. Chung
No relevant relationships to disclose
Padraig Richard Warde
No relevant relationships to disclose
Eric Winquist
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Philippe Bedard
No relevant relationships to disclose